Twist Bioscience Corporation TWST Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| DNA synthesis and protein solutions | $116.39M+26.3% | $104.76M+89.9% | $93.78M+361% | $92.63M+403% | $92.12M+415% | |
| NGS applications | $218.4M+15.7% | $212.1M+18.9% | $208.1M+23.0% | $200.61M+24.8% | $188.73M+25.4% | |
| Revenue by Geography | ||||||
| Americas | $239.37M+12.4% | $230.25M+13.1% | $225.58M+16.3% | $220.95M+19.5% | $212.95M+23.4% | |
| APAC | $29.1M+9.0% | $27M+0.4% | $26.75M+0.9% | $26.13M+0.4% | $26.7M+6.0% | |
| EMEA | $141.01M+30.5% | $134.3M+34.8% | $124.24M+34.2% | $115.19M+36.7% | $108.03M+35.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Twist Bioscience Corporation break its business down?
- Twist Bioscience Corporation (TWST) reports revenue by product across 2 parts — DNA synthesis and protein solutions and NGS applications. Each is extracted from the segment footnotes and tracked over time.
- Where does Twist Bioscience Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Twist Bioscience Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
